Nanoconjugation modulates the trafficking and mechanism of antibody induced receptor endocytosis
- 2 August 2010
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 107 (33), 14541-14546
- https://doi.org/10.1073/pnas.1006507107
Abstract
Treatment with monoclonal antibody (mAbs) is a viable therapeutic option in cancer. Recently, these mAbs such as cetuximab, herceptin, etc., have been used as targeting agents to selectively deliver chemotherapeutics to cancerous cells. However, mechanisms of nanoparticles-mAbs interactions with the target cells and its effect on intracellular trafficking and mechanism are currently unknown. In this paper, we demonstrate that the distinct patterning and dynamics of anti-EGFR (epidermal growth factor receptor) antibody cetuximab (C225)- induced EGFR internalization in pancreatic cancer cells with variable receptor expression is altered upon nanoconjugation. Nanoconjugation uniformly enhanced C225-induced EGFR endocytosis in PANC-1, AsPC-1, and MiaPaca-2 cells, influenced its compartmentalization and regulated the involvement of dynamin-2 in the endocytic processes. Receptor endocytosis and its intracellular trafficking were monitored by confocal microscopy and transmission electron microscopy. The role of dynamin-2 in EGFR endocytosis was determined after overexpressing either wild-type dynamin-2 or mutant dynamin-2 in pancreatic cancer cells followed by tracking the receptor-antibody complex internalization by confocal microscopy. Significantly, these findings demonstrate that the nanoconjugation cannot be construed as an innocuous reaction involved in attaching the targeting agent to the nanoparticle, instead it may distinctly alter the cellular processes at the molecular level, at least antibody induced receptor endocytosis. This information is critical for successful design of a nanoparticle-based targeted drug delivery system for future clinical translation.Keywords
This publication has 38 references indexed in Scilit:
- Fabrication of gold nanoparticles for targeted therapy in pancreatic cancerAdvanced Drug Delivery Reviews, 2009
- Cetuximab/C225-Induced Intracellular Trafficking of Epidermal Growth Factor ReceptorCancer Research, 2009
- Publisher's NoteExperimental Cell Research, 2008
- Trafficking of receptor tyrosine kinases to the nucleusExperimental Cell Research, 2008
- The reduced catalase expression in TrkA-induced cells leads to autophagic cell death via ROS accumulationExperimental Cell Research, 2008
- Dynamics of Dynamin during Clathrin Mediated Endocytosis in PC12 CellsPLOS ONE, 2008
- Targeted Delivery of Gemcitabine to Pancreatic Adenocarcinoma Using Cetuximab as a Targeting AgentCancer Research, 2008
- Effect of the anti-receptor ligand-blocking 225 monoclonal antibody on EGF receptor endocytosis and sortingExperimental Cell Research, 2006
- Chemistry and Properties of Nanocrystals of Different ShapesChemical Reviews, 2005
- Ultrastructural identification of uncoated caveolin-independent early endocytic vehiclesThe Journal of cell biology, 2005